Access cutting-edge advanced melanoma treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access advanced melanoma specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced melanoma treatment provided free
This is a randomized, controlled, multicenter, open-label Phase 3 clinical study comparing VO in combination with nivolumab versus Physician's Choice treatment for patients with unresectable Stage IIIb-IV cutaneous melanoma whose disease progressed on an anti PD-1 and an anti-CTLA-4 containing regimen (administered either as a combination regimen or in sequence) or who are not candidates for treatment with an anti-CTLA-4 therapy.
Sponsor: Replimune Inc.
Check if you qualify for this advanced melanoma clinical trial in Palo Alto, CA
If you're searching for advanced melanoma treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.